Here you'll find the answers to a wealth of health and wellness questions posed by Healthy Talk fans.
Listen in because what you know helps ensure healthy choices you can live with. Today on Healthy Talk, you wanted to know:
Dr. Sinatra has been suggesting nattokinase for some time to help reduce the amount of fibrin in the bloodstream to prevent clotting, thereby reducing the chance of a heart attack. Ralph Holsworth talks about other things to use, like serrapeptase for heart attack prevention. Do you have an opinion on nattokinase or serrapeptase?
Dr. Mike things that there should be more research on both of these types of therapies. Inflammation is part of most diseases, and Dr. Mike believes it's crucial to get inflammation under control to help prevent disease. Inflammation occurs when there are too many proteins within your blood.
Blood clotting also happens because of the excessive amount of proteins that are in your blood. Fibrinogen is what doctors target to help reduce blood clotting with enzymes like nattokinase or serrapeptase.
In Dr. Mike's opinion, nattokinase is the better therapy, because it targets fibrinogen more specifically and more potently.
If you have a health question or concern, Dr. Mike encourages you to write him at askdrmikesmith@radiomd.com or call in, toll-free, to the LIVE radio show (1.844.305.7800) so he can provide you with support and helpful advice.
Wednesday, 02 September 2015 10:33
Ask Dr. Mike: Nattokinase vs. Serrapeptase
Listen in as Dr. Mike provides the answers to a wealth of health and wellness questions.
Additional Info
- Segment Number: 4
- Audio File: healthy_talk/1536ht3d.mp3
- Featured Speaker: Mike Smith, MD
- Organization: Life Extension
- Guest Website: Healthy Talk MD
- Length (mins): 10
- Waiver Received: No
- Host: Mike Smith, MD
Published in
Healthy Talk w/ Dr. Michael Smith
Tagged under